bg-rating-rationales

Entity-Specific Rating Rationales

03 Mar 2026

Sun Pharma Laboratories Limited: Rating reaffirmed

Sun Pharma Laboratories Limited: Rating reaffirmed

06 Mar 2025

Sun Pharma Laboratories Limited

Sun Pharma Laboratories Limited

04 Mar 2024

Sun Pharma Laboratories Limited: Ratings reaffirmed

Sun Pharma Laboratories Limited: Ratings reaffirmed

bg-rating-crediet-reports

Entity-Specific Credit Perspective Reports

01 Apr 2026

Sun Pharma Laboratories Limited

Sun Pharma Laboratories Limited (Non-SF)

14 Apr 2025

Sun Pharma Laboratories Limited

Sun Pharma Laboratories Limited (Non-SF)

03 Apr 2024

Sun Pharma Laboratories Limited

Sun Pharma Laboratories Limited (Non-SF)

Ratings

Description
Short Term
Medium Term
Long Term
Issuer
Short-term – Fund-based/Non-fund based – Others [ICRA]A1+ -- -- --
Commercial Paper Withdrawn -- -- --
Non-Convertible Debenture -- -- * --

Our Analysts

Analyst 1

Gaurav Kushwaha

Analyst 2

Deepak Jotwani

Sector Head

Jitin Makkar
bg-rating-research

Most Trending Research Reports


View More
bg-rating-rationales

Rating Rationales

icon-download

View More

No Data Available

Credit Quality Trends and ICRA’s Outlook for FY2027

Mr. K Ravichandran,Ms. Aditi Nayar,Mr. Pratik Singhania

01 Apr 2026 04:00 PM

Road sector hits a slow lane as project awarding moderates

Mr. Suprio Banerjee,Mr. M Rajashekar Reddy

25 Feb 2026 04:00 PM

PPT Icon PPT

Podcast

View More

Media Release



View More
Ask Our Industry Analyst Get in touch with our Business Representative
Please enter your name
Please enter your mobile number
Please enter your email id
Please enter your company name
Name should not be greater than 50 characters
Please choose sector
Please enter your query
Query to have atleast ten characters
Query should not be greater than 1,000 characters
Please verify you are not a Robot.